Company
Headquarters: Huangyan, China
Employees: 2,243
CN¥4.23 Billion
CNY as of Jan. 1, 2024
US$594.8 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive Surgical, Inc. | $113.81 B |
| EssilorLuxottica SA | $90.57 B |
| Becton, Dickinson and Company | $70.33 B |
| HOYA Corp | $43.39 B |
| Alcon Inc. | $37.65 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Chimin Health Management Co., Ltd. develops, produces, and sells human drugs and medical devices in China. The company offers non-PVC soft bag double tube double valves, single valves, and single-tube double valves; plastic bottles; and other packaging forms. It also provides safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products; In Vitro diagnosis solutions; and hemodialysis supplies, as well as medical services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Huangyan, China.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Chimin Health Management Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603222 wb_incandescent